快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
林胜友,刘鲁明,吴良村,周维顺,郭勇,沈敏鹤,杨维泓,谢长生,陈良良,冯培芳.参麦注射液对胃癌化疗后免疫功能影响的观察[J].中国中西医结合杂志,1995,(8):451-453
参麦注射液对胃癌化疗后免疫功能影响的观察
Effects of Shenmai Injection on Immune Function in Stomach Cancer Patients after Chemotherapy
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  参麦注射液  胃癌  化疗  肿瘤免疫
英文关键词:Shenmai injection  stomach cancer  chemotherapy  tumor immunity
基金项目:
作者单位
林胜友 浙江中医学院附属医院 
刘鲁明 浙江中医学院附属医院 
吴良村 浙江中医学院附属医院 
周维顺 浙江中医学院附属医院 
郭勇 浙江中医学院附属医院 
沈敏鹤 浙江中医学院附属医院 
杨维泓 浙江中医学院附属医院 
谢长生 浙江中医学院附属医院 
陈良良 浙江中医学院附属医院 
冯培芳 浙江中医学院附属医院 
摘要点击次数: 1475
全文下载次数: 955
中文摘要:
      63例胃癌患者随机分组观察,结果提示,化疗结合参麦注射液组(简称参麦组)T淋巴细胞计数(ANAE)上升(P<0.05),化疗组(简称对照组)ANAE下降(P<0.05);化疗后两组OKT1值、OKT4/OKT8值均有下降,动态结果提示参麦组上述指标提前回升,第4周明显高于化疗前水平(P<0.05),对照组第4周仍处于较低水平;化疗后参麦组血清可溶性白细胞介素-2受体(sIL-2R)水平下降(P<0.05),NK、LAK水平上升(P<0.05);对照组sIL-2R水平无明显变化(P>0.05),NK、LAK水平下降(P<0.05);两组化疗前后IgA、IgM、IgG水平无明显变化(p>0.05)。表明参麦注射液可改善患者免疫功能,有助于化疗的施行。
英文摘要:
      Sixty-three cases with stomach cancer were randomized and observed, the results showed that the count of T lymphocytes in chemotherapy combined with Shenmai injection (SMI) group increased,while in control group it decreased,the difference was significant(P<0.05).The results also indicated that the count of OKT4 cells and the ratio of OKT4/OKT8 decreased after chemotherapy,but in SMI group both parameters increased in advence which were higher in the 4th week after chemotherapy than that before chemotherapy.However,the count of OKT1 cells and the ratio of OKT4/OKT8 were still in low level.Serum interleukin-2 receptor(sIL-2R) level also decreased (P<0.005),while activities of natural killer cell(NK) and lymphokine activated killer cell(LAK) level increased(P<0.05) in SMI group.Although the sIL-2R level had no change,both NK and LAK level decreased in control group.In addition,the difference of IgA,IgM,IgG level were not significant between these two groups.This suggested that SMI might improve human immune function to facilitate the chemotherapy of patients with stomach cancer.
关闭